Online citations, reference lists, and bibliographies.
← Back to Search

Generation Of Induced Pluripotent Stem Cells Using Recombinant Proteins.

H. Zhou, S. Wu, Jin Young Joo, Saiyong Zhu, D. Han, Tongxiang Lin, S. Trauger, Geoffery Bien, Susan Yao, Y. Zhu, G. Siuzdak, H. Schöler, L. Duan, S. Ding
Published 2009 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Document S1. Supplemental Experimental Procedures, One Table, and Two FiguresxDownload (1.25 MB ) Document S1. Supplemental Experimental Procedures, One Table, and Two FiguresMovie S1. Beating Cardiomyocytes Differentiated from piPSCsxDownload (9.55 MB ) Movie S1. Beating Cardiomyocytes Differentiated from piPSCs
This paper references
Cell Stem Cell 3, 568–574
Y. Shi (2008)
Cell Stem Cell Brief Report Please cite this article in press as: Zhou et al., Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins
(2009)
10.1038/nature07864
Virus free induction of pluripotency and subsequent excision of reprogramming factors
K. Kaji (2009)
10.1016/j.otohns.2009.05.016
Nature
R. Rosenfeld (2009)
10.1038/nbt1418
Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds
Danwei Huangfu (2008)
10.1074/JBC.M412430200
The NH2 Terminus of Influenza Virus Hemagglutinin-2 Subunit Peptides Enhances the Antitumor Potency of Polyarginine-mediated p53 Protein Transduction*
H. Michiue (2005)
10.1158/1535-7163.MCT-08-0078
Recombinant, refolded tetrameric p53 and gonadotropin-releasing hormone-p53 slow proliferation and induce apoptosis in p53-deficient cancer cells
Michelle Lafevre-Bernt (2008)
Mol. Cancer Ther
M Lafevre-Bernt (2008)
Cell Stem Cell Cell Stem Cell Brief Report
(2009)
10.1038/nature07061
Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors
J. Kim (2008)
10.1016/J.EURURO.2005.08.019
p53 protein transduction therapy: successful targeting and inhibition of the growth of the bladder cancer cells.
M. Inoue (2006)
Curr
J. S. Wadia (2002)
10.1126/science.1162494
Induced Pluripotent Stem Cells Generated Without Viral Integration
M. Stadtfeld (2008)
Eur. Urol
M Inoue (2006)
10.1016/j.stem.2008.05.011
A combined chemical and genetic approach for the generation of induced pluripotent stem cells.
Y. Shi (2008)
J. Biol. Chem
H Michiue (2005)
10.1016/0092-8674(93)90586-F
Cell
AC Tose (1993)
Science 322, 945–949
M. Stadtfeld (2008)
Science. Published online
J Yu (1126)
10.1038/nature07863
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells
Knut Woltjen (2009)
10.1038/nbt.1503
Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes
T. Aasen (2008)
10.1016/j.stem.2008.11.014
Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors.
W. Li (2009)
10.1016/S0958-1669(02)00284-7
Protein transduction technology.
J. Wadia (2002)
10.1038/nbt.1502
Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2
Danwei Huangfu (2008)
Nat. Biotechnol
V Pekarik (2008)
Nat. Biotechnol
10.1126/science.1172482
Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences
J. Yu (2009)
Nature 458, 771–775
P. Mohseni (2009)
Nat
M. Snitow (2008)
10.1016/j.stem.2007.05.009
Cell stem cell.
L. Zon (2007)
10.1634/stemcells.2006-0050
Reprogramming Efficiency Following Somatic Cell Nuclear Transfer Is Influenced by the Differentiation and Methylation State of the Donor Nucleus
R. Blelloch (2006)
10.1016/j.cell.2009.03.034
A Fresh Look at iPS Cells
S. Yamanaka (2009)
Curr. Opin. Biotechnol
J S Wadia (2002)
Nat. Biotechnol
D Huangfu (2008)
Cell 126, 663–676
K. Takahashi (2006)
10.1158/1078-0432.CCR-05-0384
VEGI-192, a New Isoform of TNFSF15, Specifically Eliminates Tumor Vascular Endothelial Cells and Suppresses Tumor Growth
Wen Hou (2005)
10.1016/J.PEP.2006.10.012
Refolding, purification, and activation of miniplasminogen and microplasminogen isolated from E. coli inclusion bodies.
D. Medynski (2007)
10.1016/j.cell.2007.11.019
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Kazutoshi Takahashi (2007)
10.1126/science.1164270
Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
K. Okita (2008)
10.1016/j.cell.2009.02.013
Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors
F. Soldner (2009)
Nat. Biotechnol
T Aasen (2008)
Mol
M. Lafevre-Bernt (2008)
10.1126/science.1151526
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
J. Yu (2007)
10.1016/j.stem.2008.10.004
Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds.
Y. Shi (2008)
10.1016/j.cell.2006.07.024
Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors
Kazutoshi Takahashi (2006)



This paper is referenced by
10.3724/SP.J.1008.2010.00489
Expression of human Oct4 and cell penetrating peptide fusion protein: Expression of human Oct4 and cell penetrating peptide fusion protein
Cheng-liang Zhou (2010)
Generation of an HVS-based episomally maintained gene delivery system for reprogramming adult somatic cells
Hannah Frances Brown (2012)
Neue Wege der Stammzellforschung : Reprogrammierung von differenzierten Körperzellen
Henning M. Beier (2009)
Generation of human iPS cells using direct reprogramming proteins
Nick Blazic (2011)
Cellules exprimant un peptide thérapeutique
David Kiewlich (2014)
In Vitro Models of Cellular Dedifferentiation for Regenerative Medicine
Kaylyn Renee Williams (2018)
BIO016402 300..310
Sharan Paul (2016)
Genetic Mutations in hiPSCs : Generation of Advantageous Genetic Mutations Due to Extended Passaging
Valentina Perrera (2019)
ATM, BRCA1, and Aurora A: Mechanisms of G2/M Checkpoint Control in Human Embryonic Stem Cells
Jason M. Beckta (2014)
Dental Stem Cell Banking (DSCB)
Pm Sunil (2013)
10.5772/intechopen.88878
Induced Pluripotent Stem Cells for Clinical Use
Valérie Vanneaux (2019)
10.1016/j.addr.2010.01.002
Genetically modified cells in regenerative medicine and tissue engineering.
D. Sheyn (2010)
10.1002/bies.201000033
Returning to the stem state: Epigenetics of recapitulating pre‐differentiation chromatin structure
M. Shafa (2010)
10.1007/s12015-015-9587-7
Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis
M. Barczyk (2015)
Cholesterol Disturbances in Inherited Neurodegenerative Diseases : Studies on Npc1, Ppt1 and Ctsd deficient mice
A. Mutka (2009)
10.1007/978-1-61779-225-0_7
Generation of Induced Pluripotent Stem Cells from Somatic Cells
M. Nakagawa (2011)
10.1097/MOT.0b013e32832e9424
Transplantation tolerance in an age of induced pluripotency
P. Fairchild (2009)
10.1002/jcb.22775
Teratomas from pluripotent stem cells: A clinical hurdle
Chui-Yee Fong (2010)
10.1002/jcb.24183
Assessing iPSC reprogramming methods for their suitability in translational medicine
M. Rao (2012)
Guardian of reprogramming
S. Menéndez (2010)
10.1007/978-1-62703-348-0_3
A review of the methods for human iPSC derivation.
N. Malik (2013)
10.1016/j.biomaterials.2011.03.053
Critical-size calvarial bone defects healing in a mouse model with silk scaffolds and SATB2-modified iPSCs.
Jin-Hai Ye (2011)
10.1007/s00403-011-1131-2
Dermal substitute-assisted healing: enhancing stem cell therapy with novel biomaterial design
T. Hodgkinson (2011)
10.1097/MOT.0b013e3283337e1c
Converting human pluripotent stem cells into β-cells: recent advances and future challenges
C. Mayhew (2010)
10.1016/j.joca.2016.11.015
The potential of induced pluripotent stem cells as a tool to study skeletal dysplasias and cartilage-related pathologic conditions.
H. Liu (2017)
10.1007/5584_2017_113
Stem Cells in Regenerative Cardiology.
S. Arbatlı (2018)
10.1016/B978-0-12-397898-1.00003-7
Telomere biology in stem cells and reprogramming.
L. F. Batista (2014)
10.1007/s00018-012-1078-2
Induced pluripotent stem cells for cardiac repair
Limor Zwi-Dantsis (2012)
10.5966/sctm.2013-0149
Increased Genomic Integrity of an Improved Protein‐Based Mouse Induced Pluripotent Stem Cell Method Compared With Current Viral‐Induced Strategies
H. Park (2014)
10.1007/s10545-018-0225-9
Induced pluripotent stem cells (iPSCs) as model to study inherited defects of neurotransmission in inborn errors of metabolism
Sabine Jung-Klawitter (2018)
10.1258/ebm.2009.009267
Induced pluripotent stem cells: what lies beyond the paradigm shift
J. Cox (2010)
10.1016/j.jconrel.2017.11.004
Transcription factors: Time to deliver.
A. V. Ulasov (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar